For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Adenoma With Possible Autonomous Cortisol Secretion | cortisol values after an overnight 1 mg dexamethasone suppression test: 50-138 nmol/L | 168 | None | 130 | 1208 | 547 | 1250 | View |
| Adenoma With Autonomous Cortisol Secretion | cortisol values after an overnight 1 mg dexamethasone suppression test: \> 138 nmol/L | 41 | None | 22 | 225 | 123 | 232 | View |
| Non-functioning Adenoma | cortisol values after an overnight 1 mg dexamethasone suppression test; less than 50 nmol/L | 143 | None | 145 | 1892 | 724 | 2002 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| MACE | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dylipidemia | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |